Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 115

1.

Can billing codes accurately identify rapidly progressing stage 3 and stage 4 chronic kidney disease patients: a diagnostic test study.

Jalal K, Anand EJ, Venuto R, Eberle J, Arora P.

BMC Nephrol. 2019 Jul 12;20(1):260. doi: 10.1186/s12882-019-1429-4.

2.

The impact of systematic review of status 7 patients on the kidney transplant waitlist.

Kataria A, Gowda M, Lamphron BP, Jalal K, Venuto RC, Gundroo AA.

BMC Nephrol. 2019 May 16;20(1):174. doi: 10.1186/s12882-019-1362-6.

3.

Influence of Calcineurin Inhibitor and Sex on Mycophenolic Acid Pharmacokinetics and Adverse Effects Post-Renal Transplant.

Meaney CJ, Sudchada P, Consiglio JD, Wilding GE, Cooper LM, Venuto RC, Tornatore KM.

J Clin Pharmacol. 2019 Oct;59(10):1351-1365. doi: 10.1002/jcph.1428. Epub 2019 May 6.

PMID:
31062373
4.

The impact of tacrolimus exposure on extrarenal adverse effects in adult renal transplant recipients.

Campagne O, Mager DE, Brazeau D, Venuto RC, Tornatore KM.

Br J Clin Pharmacol. 2019 Mar;85(3):516-529. doi: 10.1111/bcp.13811. Epub 2019 Jan 4.

PMID:
30414331
5.

Tacrolimus Population Pharmacokinetics and Multiple CYP3A5 Genotypes in Black and White Renal Transplant Recipients.

Campagne O, Mager DE, Brazeau D, Venuto RC, Tornatore KM.

J Clin Pharmacol. 2018 Sep;58(9):1184-1195. doi: 10.1002/jcph.1118. Epub 2018 May 18.

6.

Utility of Serial Protocol Biopsies Performed After 1 Year in Predicting Long-Term Kidney Allograft Function According to Histologic Phenotype.

Zachariah MS, Dwivedi AK, Yip CS, Chang SS, Gundroo A, Venuto RC, Tomaszewski J, Patel SK, Sharma R.

Exp Clin Transplant. 2018 Aug;16(4):391-400. doi: 10.6002/ect.2016.0323. Epub 2017 Dec 5.

7.

An observational study of the quality of care for chronic kidney disease: a Buffalo and Albany, New York metropolitan area study.

Arora P, Elkin PL, Eberle J, Bono JJ, Argauer L, Murray BM, Ram R, Venuto RC.

BMC Nephrol. 2015 Dec 3;16:199. doi: 10.1186/s12882-015-0194-2.

8.

Association of Extrarenal Adverse Effects of Posttransplant Immunosuppression With Sex and ABCB1 Haplotypes.

Venuto RC, Meaney CJ, Chang S, Leca N, Consiglio JD, Wilding GE, Brazeau D, Gundroo A, Nainani N, Morse SE, Cooper LM, Tornatore KM.

Medicine (Baltimore). 2015 Sep;94(37):e1315. doi: 10.1097/MD.0000000000001315.

9.

Influence of sex and race on mycophenolic acid pharmacokinetics in stable African American and Caucasian renal transplant recipients.

Tornatore KM, Meaney CJ, Wilding GE, Chang SS, Gundroo A, Cooper LM, Gray V, Shin K, Fetterly GJ, Prey J, Clark K, Venuto RC.

Clin Pharmacokinet. 2015 Apr;54(4):423-34. doi: 10.1007/s40262-014-0213-7.

10.

Evaluation of a Renal Transplant Program for Incarcerated ESRD Patients.

Panesar M, Bhutani H, Blizniak N, Gundroo A, Zachariah M, Pelley W, Venuto R.

J Correct Health Care. 2014 Jul;20(3):220-227. Epub 2014 Jun 16.

PMID:
24934840
11.

Validity and reliability of a novel immunosuppressive adverse effects scoring system in renal transplant recipients.

Meaney CJ, Arabi Z, Venuto RC, Consiglio JD, Wilding GE, Tornatore KM.

BMC Nephrol. 2014 Jun 12;15:88. doi: 10.1186/1471-2369-15-88.

12.

Alemtuzumab and minimization immunotherapy in kidney transplantation: long-term results of comparison with rabbit anti-thymocyte globulin and standard triple maintenance therapy.

Zachariah M, Nader ND, Brar J, Singh N, Venuto R, Patel S, Said M, Laftavi MR, Pankewycz O.

Transplant Proc. 2014 Jan-Feb;46(1):94-100. doi: 10.1016/j.transproceed.2013.07.067.

PMID:
24507032
13.

Interventions to reduce clinical inertia in cardiac risk factor management in renal transplant recipients.

Kohok DD, Shah S, Kumar R, Venuto L, Gudleski G, Venuto R.

J Clin Hypertens (Greenwich). 2014 Feb;16(2):127-32. doi: 10.1111/jch.12249. Epub 2014 Jan 17.

14.

Nuclear translocation of nuclear factor of activated T cells (NFAT) as a quantitative pharmacodynamic parameter for tacrolimus.

Maguire O, Tornatore KM, O'Loughlin KL, Venuto RC, Minderman H.

Cytometry A. 2013 Dec;83(12):1096-104. doi: 10.1002/cyto.a.22401. Epub 2013 Oct 17.

15.

Sex differences in cyclosporine pharmacokinetics and ABCB1 gene expression in mononuclear blood cells in African American and Caucasian renal transplant recipients.

Tornatore KM, Brazeau D, Dole K, Danison R, Wilding G, Leca N, Gundroo A, Gillis K, Zack J, DiFrancesco R, Venuto RC.

J Clin Pharmacol. 2013 Oct;53(10):1039-47. doi: 10.1002/jcph.123. Epub 2013 Jul 3.

PMID:
23908147
16.

Multiple pathologies in the kidney biopsy of a recently pregnant woman.

Kandukurti K, Sun J, Venuto R.

Case Rep Nephrol Urol. 2013 Jan;3(1):9-15. doi: 10.1159/000346862. Epub 2013 Jan 26.

17.

Race and drug formulation influence on mycophenolic acid pharmacokinetics in stable renal transplant recipients.

Tornatore KM, Sudchada P, Attwood K, Wilding GE, Gundroo AC, DiFrancesco R, Gray V, Venuto RC.

J Clin Pharmacol. 2013 Mar;53(3):285-93. doi: 10.1177/0091270012447814. Epub 2013 Jan 24.

PMID:
23444283
18.

Comparison of 12-hour creatinine clearance and estimated glomerular filtration rate in renal transplant recipients.

Kumar R, Pendyala P, Attwood K, Gray V, Venuto R, Tornatore K.

Ren Fail. 2013;35(3):333-7. doi: 10.3109/0886022X.2012.757824. Epub 2013 Jan 29.

PMID:
23356545
19.

A comprehensive review of hypertension in pregnancy.

Mustafa R, Ahmed S, Gupta A, Venuto RC.

J Pregnancy. 2012;2012:105918. doi: 10.1155/2012/105918. Epub 2012 May 23. Review.

20.

Assessment of cardiovascular risk factors after renal transplantation: a step towards reducing graft failure.

Kumar R, Brar J, Yacoub R, Khan T, Zachariah M, Venuto R.

Transplant Proc. 2012 Jun;44(5):1270-4. doi: 10.1016/j.transproceed.2012.01.111.

PMID:
22663999
21.

Acute oliguric renal failure in HELLP syndrome: case report and review of literature.

Gupta A, Ferguson J, Rahman M, Weber-Shrikant E, Venuto R.

Ren Fail. 2012;34(5):653-6. doi: 10.3109/0886022X.2012.660856. Epub 2012 Feb 27.

PMID:
22364519
22.
23.

Effect of steroid-free low concentration calcineurin inhibitor maintenance immunosuppression regimen on renal allograft histopathology and function.

Nainani N, Patel N, Tahir N, Kumar R, Weber-Shrikant E, Gundroo AA, Murray BM, Tornatore KM, Blessios GA, Venuto RC.

Nephrol Dial Transplant. 2012 May;27(5):2077-83. doi: 10.1093/ndt/gfr608. Epub 2011 Nov 5.

PMID:
22058172
24.

Mycophenolic acid pharmacokinetics during maintenance immunosuppression in African American and Caucasian renal transplant recipients.

Tornatore KM, Sudchada P, Dole K, DiFrancesco R, Leca N, Gundroo AC, Danison RT, Attwood K, Wilding GE, Zack J, Forrest A, Venuto RC.

J Clin Pharmacol. 2011 Aug;51(8):1213-22. doi: 10.1177/0091270010382909. Epub 2011 Jan 5.

PMID:
21209244
25.

Mild acute kidney injury is associated with increased mortality after cardiac surgery in patients with eGFR < 60 mL/min/1.73 m(2).

Kolli H, Rajagopalam S, Patel N, Ranjan R, Venuto R, Lohr J, Arora P.

Ren Fail. 2010;32(9):1066-72. doi: 10.3109/0886022X.2010.510616.

PMID:
20863211
26.

Use of anti-CD20 antibody in the treatment of post-transplant glomerulonephritis.

Damodar A, Mustafa R, Bhatnagar J, Panesar M, Gundroo A, Zachariah M, Blessios G, Tornatore K, Weber-Shrikant E, Venuto R.

Clin Transplant. 2011 May-Jun;25(3):375-9. doi: 10.1111/j.1399-0012.2010.01245.x. Epub 2010 Apr 5.

PMID:
20384712
27.

High volumes of intravenous fluid during cardiac surgery are associated with increased mortality.

Pradeep A, Rajagopalam S, Kolli HK, Patel N, Venuto R, Lohr J, Nader ND.

HSR Proc Intensive Care Cardiovasc Anesth. 2010;2(4):287-96.

28.

CKD in MYH9-related disorders.

Singh N, Nainani N, Arora P, Venuto RC.

Am J Kidney Dis. 2009 Oct;54(4):732-40. doi: 10.1053/j.ajkd.2009.06.023. Epub 2009 Sep 2. Review.

PMID:
19726116
29.

Kidney transplantation and pregnancy.

Zachariah MS, Tornatore KM, Venuto RC.

Curr Opin Organ Transplant. 2009 Aug;14(4):386-91. doi: 10.1097/MOT.0b013e32832dbc34. Review.

PMID:
19512929
30.

Cross Reactive Epitope Group antibodies in sensitized kidneys transplant recipients was associated with early acute Antibody Mediated Rejection.

Nainani N, Singh N, Shanahan T, Damodar A, Parimoo N, Ummadi S, Qazi Y, Murray BM, Tornatore KM, Ciccirella JC, Blessios GA, Venuto RC.

Transpl Immunol. 2009 Jan;20(3):113-7. doi: 10.1016/j.trim.2008.10.009. Epub 2008 Nov 6.

PMID:
18996198
31.

Preoperative use of angiotensin-converting enzyme inhibitors/angiotensin receptor blockers is associated with increased risk for acute kidney injury after cardiovascular surgery.

Arora P, Rajagopalam S, Ranjan R, Kolli H, Singh M, Venuto R, Lohr J.

Clin J Am Soc Nephrol. 2008 Sep;3(5):1266-73. doi: 10.2215/CJN.05271107. Epub 2008 Jul 30.

32.

Mycophenolate mofetil in the treatment of retroperitoneal fibrosis.

Khalil F, Mir MA, Venuto RC.

Clin Rheumatol. 2008 May;27(5):679-81. doi: 10.1007/s10067-007-0826-4. Epub 2008 Jan 8.

PMID:
18185904
33.

Acute renal failure during pregnancy secondary to spontaneous perirenal hematoma.

Singh N, Neubauer BE, Venuto RC.

Ren Fail. 2007;29(8):1053-4.

PMID:
18067056
34.

Postpartum hemolytic uremic syndrome in a patient with preexisting hypertension and resolving preeclampsia.

Karam JS, Pitiranggon P, Wheat H, Stefanick B, Venuto RC.

Clin Nephrol. 2007 Jul;68(1):38-41.

PMID:
17703834
35.

Early and severe hyperparathyroidism associated with hypercalcemia after renal transplant treated with cinacalcet.

Leca N, Laftavi M, Gundroo A, Kohli R, Min I, Karam J, Sridhar N, Blessios G, Venuto R, Pankewycz O.

Am J Transplant. 2006 Oct;6(10):2391-5. Epub 2006 Jul 26.

36.
37.

Anti-CD20 monoclonal antibody (Rituximab) for life-threatening hemolytic-uremic syndrome.

Yassa SK, Blessios G, Marinides G, Venuto RC.

Clin Transplant. 2005 Jun;19(3):423-6.

PMID:
15877809
38.

Pharmacokinetics and pharmacodynamic response of methylprednisolone in premenopausal renal transplant recipients.

Tornatore KM, Gilliland-Johnson KK, Farooqui M, Reed KA, Venuto RC.

J Clin Pharmacol. 2004 Sep;44(9):1003-11.

PMID:
15317828
39.

Human immunodeficiency virus-associated nephropathy: a primary care perspective.

Olatinwo T, Hewitt RG, Venuto RC.

Arch Intern Med. 2004 Feb 9;164(3):333-6. Review.

PMID:
14769631
40.

Randomized, open-label preference study of two cyclosporine capsule formulations (usp modified) in stable solid-organ transplant recipients.

Steinberg SM, Venuto RC, Kuruvila CK, Taylor DO, Anil Kumar MS, Groothuis JR, Ryan J, Greco R, Yeldandi V, Ashraf T, Boodhoo T; Prefer Study Group.

Clin Ther. 2003 Jul;25(7):2037-52.

PMID:
12946549
41.

Donor calculi induced acute renal failure.

Qazi YA, Ali Y, Venuto RC.

Ren Fail. 2003 Mar;25(2):315-22.

PMID:
12739839
42.

Increased NO-mediated and reduced TxA2-dependent responses in skeletal muscle arterioles in pregnancy.

Ungvari Z, Brown G, Venuto R, Koller A, Losonczy G.

Hypertens Pregnancy. 2002;21(2):135-46.

PMID:
12175442
43.

Enhanced vascular effects of the Ca(2+) channel agonist Bay K 8644 in pregnant rabbits.

Venuto R, Brown G, Schoenl M, Losonczy G.

Am J Physiol Regul Integr Comp Physiol. 2002 Apr;282(4):R952-9.

44.

Ganciclovir pharmacokinetics and cytokine dynamics in renal transplant recipients with cytomegalovirus infection.

Tornatore KM, Garey KW, Saigal N, Reed K, Murray B, Ingalls E, DiFrancesco R, Forrest A, Morse G, Venuto R.

Clin Transplant. 2001 Oct;15(5):297-308.

PMID:
11678955
45.

Thromboxane receptors in human kidney tissues.

Brown GP, Venuto RC.

Prostaglandins Other Lipid Mediat. 1999 Jun;57(4):179-88.

PMID:
10402213
46.

Hemodynamic and renal effects of U-46619, a TXA2/PGH2 analog, in late-pregnant rats.

Kriston T, Venuto RC, Baylis C, Losonczy G.

Am J Physiol. 1999 Mar;276(3):R831-7. doi: 10.1152/ajpregu.1999.276.3.R831.

PMID:
10070145
47.
48.

Monitoring and diagnosis of cytomegalovirus infection in renal transplantation.

Murray BM, Amsterdam D, Gray V, Myers J, Gerbasi J, Venuto R.

J Am Soc Nephrol. 1997 Sep;8(9):1448-57.

49.

Gestational resistance to the pulmonary vasoconstrictor effect of the TxA2 mimetic U-46619: possible mechanism.

Losonczy G, Brown G, Mucha I, Klocke R, Muller V, Merkely B, Tornoci L, Rosivall L, Venuto R.

Am J Physiol. 1997 Jun;272(6 Pt 2):R1734-9.

PMID:
9227584
50.

Impact of surgery on nitric oxide in rats: evidence for activation of inducible nitric oxide synthase.

Losonczy G, Bloch JF, Samsell L, Schoenl M, Venuto R, Baylis C.

Kidney Int. 1997 Jun;51(6):1943-9.

Supplemental Content

Loading ...
Support Center